CALADRIUS BIOSCIENCES, INC. - FORM 10-Q - EX-32.2 - EXHIBIT 32.2 - May 5, 2016

Attached files

file filename
10-Q - 10-Q 03.31.2016 - CALADRIUS BIOSCIENCES, INC.clbs-10qx20160331.htm
EX-4.1 - EXHIBIT 4.1 FORM OF WARRANT - CALADRIUS BIOSCIENCES, INC.exhibit41formofwarrant.htm
EX-10.1 - EXHIBIT 10.1 UPA - CALADRIUS BIOSCIENCES, INC.exhibit101unitpurchaseagre.htm
EX-10.2 - EXHIBIT 10.2 OPERATING AGREEMENT - CALADRIUS BIOSCIENCES, INC.exhibit102operatingagreeme.htm
EX-10.8 - EXHIBIT 10.8 RRA - CALADRIUS BIOSCIENCES, INC.exhibit108registrationrigh.htm
EX-10.5 - EXHIBIT 10.5 PRETI PCT - CALADRIUS BIOSCIENCES, INC.exhibit105pctpretiagreement.htm
EX-10.4 - EXHIBIT 10.4 PRETI CLBS - CALADRIUS BIOSCIENCES, INC.exhibit104clbspretiagreeme.htm
EX-31.2 - EXHIBIT 31.2 - CALADRIUS BIOSCIENCES, INC.clbs-ex312_20160331xq1.htm
EX-31.1 - EXHIBIT 31.1 MAZZO - CALADRIUS BIOSCIENCES, INC.clbs-ex311_20160331xq1.htm
EX-32.1 - EXHIBIT 32.1 - CALADRIUS BIOSCIENCES, INC.clbs-ex321_20160331xq1.htm
EX-10.6 - EXHIBIT 10.6 OXFORD THIRD - CALADRIUS BIOSCIENCES, INC.exhibit106thirdamoxford.htm
EX-10.3 - EXHIBIT 10.3 TECH LIC* - CALADRIUS BIOSCIENCES, INC.exhibit103technologylicens.htm
EX-10.7 - EXHIBIT 10.7 SPA - CALADRIUS BIOSCIENCES, INC.exhibit107securitiespurcha.htm
Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of Caladrius Biosciences, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2016 filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph Talamo, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
 

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the results of operations of the Company for the periods presented.
 
Dated:  May 5, 2016

 
 
/s/ Joseph Talamo
 
Joseph Talamo
 
Senior Vice President and Chief Financial Officer
 
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.
 
A signed original of this written statement required by Section 906 has been provided to Caladrius Biosciences, Inc. and will be retained by Caladrius Biosciences, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 


CALADRIUS BIOSCIENCES, INC. Reports